Reilly Thomas Charles
- SEC CIK
- 0001827590
No open-market purchases or sales filed in the past year.
Current role at each company
- AMRN Amarin Corp PLCEVP and CFOas of Jul 1, 2024
- TVRD Tvardi Therapeutics, Inc.Chief Financial Officeras of Mar 4, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Reilly Thomas Charles as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TVRD Tvardi Therapeutics, Inc.
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2022 (view filing) | Mar 3 | 1 day | Reilly Thomas CharlesChief Financial Officer | SSale | −2.04K | $11.38 | −$23.3K | −5.1%37.8K after | |
| Sep 1, 2021 (view filing) | Aug 30 | 2 days | Reilly Thomas CharlesChief Financial Officer | SSale | −1.98K | $14.20 | −$28.1K | −37.2%3.35K after |